Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€41.80
12.05.22
-
12.05.23
-6.22%
13.05.23

DirectorDealer 
12.05.22 50%
buy
Dottikon ES Holding AG

Start price
Target price
Perf. (%)
€48.00
11.05.22
€54.00
11.05.23
0.00%
11.05.23

Could be very worthwhile Investment >20% year
Small challenges to pay loans and raise capital
tbackenh 
11.05.22 80%
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€16.10
07.05.22
€20.00
07.05.23
222.26%
08.05.23

Could be very worthwhile Investment >20% year
melinda 
07.05.22 50%
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.00
06.05.22
-
06.05.23
-24.17%
15.05.22

Risky Investment
Wolf_of_WS 
06.05.22 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€55.10
03.05.22
€60.00
03.05.23
-22.67%
25.05.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
03.05.22 50%
buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€1.43
02.05.22
€1.00
02.05.23
18.02%
05.05.22

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
me8 
02.05.22 0%
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€1.56
01.05.22
-
01.05.23
-24.58%
14.05.22

Risky Investment
bundfuture 
01.05.22 50%
sell
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€8.03
01.05.22
-
01.05.23
-12.75%
24.04.23

Risky Investment
Higher risks for its business
High valuation
Lokrim 
01.05.22 20%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.52
28.04.22
-
28.04.23
-2.36%
30.04.22

Risky Investment
Wolf_of_WS 
28.04.22 50%
sell
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.37
28.04.22
€2.00
28.04.23
0.74%
03.08.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
geldnutzer 
28.04.22 50%
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€48.92
25.04.22
€120.00
03.02.25
-12.94%
17:18

Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
fabinator 
25.04.22 90%
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€8.69
22.04.22
-
22.04.23
3.54%
30.04.22

Could be worthwhile Investment >10% per year
Vassago1 
22.04.22 50%
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€6.60
21.04.22
-
21.04.23
4.15%
01.05.22

Risky Investment
bundfuture 
21.04.22 50%
buy
Curis Inc.

Start price
Target price
Perf. (%)
€1.14
19.04.22
-
19.04.23
-21.19%
01.05.22

Risky Investment
blaugold 
19.04.22 50%
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€5.99
19.04.22
-
12.04.24
-68.19%
12.04.24

Could be worthwhile Investment >10% per year
robertinio 
19.04.22 100%
sell
Inovio Pharma

Start price
Target price
Perf. (%)
€3.05
12.04.22
€1.60
12.04.23
-30.60%
03.08.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
12.04.22 50%
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€9.86
12.04.22
-
12.04.23
-0.02%
16.04.22

Could be worthwhile Investment >10% per year
Vassago1 
12.04.22 50%
buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€21.85
12.04.22
-
12.04.23
-9.84%
12.04.23

Saftman 
12.04.22 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€52.93
11.04.22
€40.00
11.04.23
4.10%
03.05.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
11.04.22 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.75
11.04.22
-
11.04.23
-41.07%
08.06.22

Could be worthwhile Investment >10% per year
melinda 
11.04.22 50%
sell
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.64
06.04.22
€0.000
06.04.23
-22.00%
18.04.22

Could be worthwhile Investment >10% per year
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
dimontalban 
06.04.22 50%
sell
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.64
06.04.22
€1.00
06.04.23
-22.00%
18.04.22

Probably not worthwhile Investment
Decining EBIT margin than peer group
overvalued
Very low/no dividend yield expected
Marianka 
06.04.22 70%
sell
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.76
04.04.22
€0.000
04.04.23
-33.28%
18.04.22

EBIT decline > 20% expected
Revenue decline > 20% expected
Very low/no dividend yield expected
Sustainability is not important
Marianka 
04.04.22 50%
sell
Protalix Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.76
04.04.22
€0.000
04.04.23
-35.27%
02.06.22

Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline > 20% expected
overvalued
dimontalban 
04.04.22 40%
buy
Paul Hartmann AG

Start price
Target price
Perf. (%)
€326.00
04.04.22
-
04.04.23
-31.60%
05.04.23

DirectorDealer 
04.04.22 50%